Inventor
RUCHELMAN ALEXANDER L
US55 patents
⚠️ This page may combine multiple inventors who share the name “RUCHELMAN ALEXANDER L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
24 patentsUS9796698B2Oct 24, 2017
Isoindoline compounds and methods of their use
CELGENE CORP10 citations93
US9447070B2Sep 20, 2016
5-substituted isoindoline compounds
CELGENE CORP17 citations93
US9828361B2Nov 28, 2017
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP12 citations92
US9920027B2Mar 20, 2018
4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP4 citations84
US9822094B2Nov 21, 2017
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP9 citations84
US9801868B2Oct 31, 2017
5-substituted isoindoline compounds
CELGENE CORP11 citations84
US9309219B2Apr 12, 2016
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP8 citations84
US9067912B2Jun 30, 2015
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,8-dione
CELGENE CORP5 citations83
US9181216B2Nov 10, 2015
4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP3 citations74
US10385037B2Aug 20, 2019
4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP2 citations73
US10189814B2Jan 29, 2019
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP2 citations73
US9126906B2Sep 8, 2015
Asymmetric synthetic processes for the preparation of aminosulfone compounds
CELGENE CORP5 citations71
US9434689B2Sep 6, 2016
Processes for the preparation of isoindole compounds and isotopologues thereof
CELGENE CORP3 citations69
US8981117B2Mar 17, 2015
Processes for the preparation of isoindole compounds and isotopologues thereof
CELGENE CORP4 citations69
US11414399B2Aug 16, 2022
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP0 citations62
US9303014B2Apr 5, 2016
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
CELGENE CORP1 citations61
US9266858B2Feb 23, 2016
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
CELGENE CORP1 citations61
US7470723B2Dec 30, 2008
Diphenylethylene compounds and uses thereof
CELGENE CORP4 citations60
US9187417B2Nov 17, 2015
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
CELGENE CORP3 citations58
US9133161B2Sep 15, 2015
Processes for preparing isoindoline-1,3-dione compounds
CELGENE CORP2 citations57
US12049470B2Jul 30, 2024
MK2 inhibitors, the synthesis thereof, and intermediates thereto
CELGENE CORP0 citations55
US10669257B2Jun 2, 2020
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP0 citations52
US10434095B2Oct 8, 2019
3-(1-oxo-4-((4-((3-oxomorpholino)methyl)benzyl)oxy)isoindolin-2-yl)piperidine-2,6-dione and isotopologues thereof
CELGENE CORP0 citations52
USRE46639EDec 19, 2017
4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP0 citations52
UNIV RUTGERS
11 patentsUS7517867B2Apr 14, 2009
Topoisomerase-targeting agents
UNIV RUTGERS10 citations84
US7208492B2Apr 24, 2007
Topoisomerase-targeting agents
UNIV RUTGERS12 citations84
US7319105B2Jan 15, 2008
Cytotoxic agents
UNIV RUTGERS14 citations83
US7858627B2Dec 28, 2010
Topoisomerase-targeting agents
UNIV RUTGERS6 citations74
US7517883B2Apr 14, 2009
Solubilized topoisomerase poisons
UNIV RUTGERS6 citations74
US7049315B2May 23, 2006
Solubilized topoisomerase poisons
UNIV RUTGERS10 citations74
US6992089B2Jan 31, 2006
Nitro and amino substituted topoisomerase agents
UNIV RUTGERS9 citations74
US6987109B2Jan 17, 2006
Solubilized topoisomerase poison agents
UNIV RUTGERS7 citations74
US6964964B2Nov 15, 2005
Topoisomerase poison agents
UNIV RUTGERS11 citations74
US7781587B2Aug 24, 2010
Solubilized topoisomerase poisons
UNIV RUTGERS4 citations63
US7468366B2Dec 23, 2008
Cytotoxic agents
UNIV RUTGERS4 citations62
CELGENE CAR LLC
7 patentsUS10882867B2Jan 5, 2021
Forms and compositions of a MK2 inhibitor
CELGENE CAR LLC8 citations82
US10894796B2Jan 19, 2021
MK2 inhibitors, synthesis thereof, and intermediates thereto
CELGENE CAR LLC8 citations80
US11124525B2Sep 21, 2021
Heteroaryl compounds useful as MK2 inhibitors
CELGENE CAR LLC5 citations72
US11098057B2Aug 24, 2021
9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno[3,2-F]quinolin-8-one compounds and uses thereof
CELGENE CAR LLC5 citations72
US11760763B2Sep 19, 2023
Heteroaryl compounds useful as MK2 inhibitors
CELGENE CAR LLC0 citations61
US11629153B2Apr 18, 2023
Forms and compositions of a MK2 inhibitor
CELGENE CAR LLC1 citations60
US11655257B2May 23, 2023
MK2 inhibitors, synthesis thereof, and intermediates thereto
CELGENE CAR LLC1 citations59
MULLER GEORGE W
3 patentsRUCHELMAN ALEXANDER L
2 patentsUS8153659B2Apr 10, 2012
4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
RUCHELMAN ALEXANDER L30 citations95
US8614328B2Dec 24, 2013
4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
RUCHELMAN ALEXANDER L3 citations72
MAN HON-WAH
1 patentMULLER GEORGE
1 patentLAVOIE EDMOND J
1 patentShowing the top 50 of 55 patents by PatentIndex Score.